Collaborating Authors

On firm specific characteristics of pharmaceutical generics and incentives to permanence under fuzzy conditions Artificial Intelligence

The aim of this paper is to develop a methodology that is useful for analysing from a microeconomic perspective the incentives to entry, permanence and exit in the market for pharmaceutical generics under fuzzy conditions. In an empirical application of our proposed methodology, the potential towards permanence of labs with different characteristics has been estimated. The case we deal with is set in an open market where global players diversify into different national markets of pharmaceutical generics. Risk issues are significantly important in deterring decision makers from expanding in the generic pharmaceutical business. However, not all players are affected in the same way and/or to the same extent. Small, non-diversified generics labs are in the worse position. We have highlighted that the expected NPV and the number of generics in the portfolio of a pharmaceutical lab are important variables, but that it is also important to consider the degree of diversification. Labs with a higher potential for diversification across markets have an advantage over smaller labs. We have described a fuzzy decision support system based on the Mamdani model in order to determine the incentives for a laboratory to remain in the market both when it is stable and when it is growing.

Why Alexion Pharmaceuticals Is Overvalued

Forbes - Tech

David Hallal, chief executive officer of Alexion Pharmaceuticals Inc., poses in this undated handout photo released to the media on Wednesday, May 6, 2015. About two years ago, he quit that company and appointed his successor. And last month, that successor and his chief financial officer left in the wake of an accounting scandal. Yet despite a 13% drop in its stock price after their departure, the stock has recovered what it lost. I think its limited growth potential means the stock is dead money.

Recursion Pharmaceuticals Closes Additional $2.15M in Series A Funding


Recursion Pharmaceuticals, a Salt Lake City, UT-based drug discovery company, closed an additional $2.15M in Series A funding. The additional funding, which brought the total amount raised in the round to $15.05M, came from several individual investors and Felicis Ventures. They joined Lux Capital, Obvious Ventures, Epic Ventures, Data Collective, AME Cloud Ventures, Wild Basin Investments, and other angel investors. The company intends to use the funds to extend its drug and target discovery technology into new indication areas, such as aging, inflammation, infectious disease, oncology and diagnostics. Led by Chris Gibson, Ph.D., CEO, Recursion uses a novel drug screening platform which combines experimental biology and bioinformatics to identify treatments for multiple rare genetic diseases.

Stocks Algo Trading Bot Morning Huddle MTB Market Analysis


"Mighty Mouse" Leads The Daily Regime of Optimized Algorithms Good morning. Mighty Mouse, today's high performing algorithm, headlines the Holly Morning Huddle Report.As of today, Wednesday, January 10, 2018, the return from my trading performance since January 1 stands at 113.9 accumulated profit points vs the benchmark SPY's performance of 50.9 points over the same period. On Tuesday my performance was higher 1.0 in Risk-Off mode (shown above). Risk-Off mode is where trades are not extended and exits are bounded by predetermined time in trade limits absent other reasons to exit (e.g., price target or stop loss reached, etc.) On Tuesday. the SPY was up .6. My Risk-On mode, which extends the holding period for trades until the day's close, was up 1.8 points.10

Artificial Intelligence in Stadium Market Size, Analysis, Opportunities and Future Prospects 2026


Each segment of the Artificial Intelligence in Stadium market is extensively evaluated in the research study. The segmental analysis offered in the report pinpoints key opportunities available in the Artificial Intelligence in Stadium market through leading segments. The regional study of the Artificial Intelligence in Stadium market included in the report helps readers to gain a sound understanding of the development of different geographical markets in recent years and also going forth. We have provided a detailed study on the critical dynamics of the Artificial Intelligence in Stadium market, which include the market influence and market effect factors, drivers, challenges, restraints, trends, and prospects. The research study also includes other types of analysis such as qualitative and quantitative.